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Abstract 
Background and aim: Vitamins, trace elements and certain polyunsaturated fatty acids are important in the 
maintenance of physical functions and prevention of diet-related diseases. Several factors influence the 
nutrient status, especially in women. Additionally, the nutritional requirement of women is increased in 
specific life stages, for example during pregnancy. Therefore, the aim of this thesis was to evaluate the 
status of vitamin D, long-chain (LC) omega-3 (n-3) polyunsaturated fatty acids (PUFAs) and iron in women 
who are in certain stages of life.  
Methods: The nutrient status was examined within the scope of the cross-sectional nationwide “Vitamin 
and mineral status among German women” study, which analyzed the status of specific nutrients in 2367 
women (18 - 66 years). The recruitment took place in cooperation with 125 general practitioners and 
gynecologists between April 2013 and March 2015. The vitamin D status of pregnant (n = 429) and 
breastfeeding women (n = 124) was assessed compared to non-pregnant and non-breastfeeding (NPNB) 
women of the same age, region and season of recruiting. Serum 25-hydroxyvitamin D (25(OH)D) – indicator 
of the vitamin D status – was determined by chemiluminescence immunoassay. The LC n-3 PUFA status 
was investigated in pregnant women in the third trimester (n = 213), breastfeeding women (n = 127) and 
middle-aged women (40 to 60 years) (n = 446). The evaluation was conducted by the omega-3 index, which 
is the relative eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) of the total fatty acids in the 
erythrocyte membranes. The iron status was estimated in women of reproductive age (n = 178) by the 
concentration of hemoglobin (Hb), ferritin, soluble transferrin receptor (sTfR) and the sTfR-ferritin index. 
Results: Pregnant and breastfeeding women had a 3.7 and 4.0, respectively, times higher risk of vitamin D 
deficiency (25(OH)D concentrations < 25.0 nmol/L) compared to NPNB women who also showed a high 
prevalence of an inadequate vitamin D status. The omega-3 index was higher in pregnant women than in 
breastfeeding women (6.40 ± 1.31% vs. 5.50 ± 1.34%). However, the status is probably insufficient in 
87.1% of these pregnant and breastfeeding women. A total of 97.3% of the middle-aged women (40 - 
60 years) showed an omega-3 index less than 8%, which is associated with an increased risk of 
cardiovascular death. An inadequate iron status (ferritin < 20 µg/L and/or Hb < 12 g/dL) was prevalent in 
16.3% of women of reproductive age.  
Conclusion: The vitamin D status of pregnant and breastfeeding women as well as of NPNB women of the 
same age needs to be improved. The determination of the vitamin D status with the highest health 
advantage is necessary. Middle-aged women and possibly also pregnant and breastfeeding women have to 
increase their LC n-3 PUFA status. In further studies, the optimal LC n-3 PUFA status during pregnancy and 
breastfeeding period should be investigated. For the enhancement of the vitamin D and LC n-3 PUFAs 
status exist numerous opportunities, which suitability requires further investigations. Women of reproductive 
age should ensure an adequate iron intake to maintain their iron status. Therefore, educational work is 
necessary to inform about the different iron sources and their individual bioavailability. 
Trial registration: German Clinical Trial Register DRKS00004789 
Keywords: nutrient status, women, Germany 
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Zusammenfassung 
Hintergrund und Ziel: Vitamine, Spurenelemente und bestimmte mehrfach ungesättigte Fettsäuren spielen 
eine wichtige Rolle in der Aufrechterhaltung von Körperfunktionen und in der Prävention von 
ernährungsassoziierten Erkrankungen. Insbesondere bei Frauen wird der Nährstoffstatus durch zahlreiche 
Faktoren beeinflusst und ist zudem in bestimmten Lebensphasen, wie der Schwangerschaft, erhöht. Das 
Ziel dieser Arbeit war daher den Status von Vitamin D, langkettigen Omega-3 Fettsäuren und Eisen bei 
Frauen in ausgewählten Lebensperioden zu untersuchen.  
Methodik: Der Nährstoffstatus wurde im Rahmen der bundesweiten Querschnittsstudie „Vitamin- und 
Mineralstoffversorgung bei Frauen in Deutschland“ erfasst. Die Studie analysierte den Status an 
ausgewählten Nährstoffen bei 2367 Frauen (18 - 66 Jahre). Die Rekrutierung erfolgte in Zusammenarbeit 
mit 125 Allgemeinmedizinern und Gynäkologen zwischen April 2013 und März 2015. Der Vitamin D Status 
von Schwangeren (n = 429) und Stillenden (n = 124) wurde im Vergleich zu Nichtschwangeren und 
Nichtstillenden desselben Alters sowie der gleichen Rekrutierungsregion und -jahreszeit beurteilt. Die 
Messung der Serum 25-Hydroxyvitamin D Konzentration (25(OH)D) – Indikator für den Vitamin D Status – 
erfolgte mittels Chemilumineszenz-Immunoassay. Der Omega-3 Status wurde bei Schwangeren im dritten 
Trimester (n = 213), Stillenden (n = 127) und Frauen im mittleren Alter (40 - 60 Jahren) (n = 446) anhand 
des Omega-3 Index analysiert – relative Eicosapentaensäure (EPA) und Docosahexaensäure (DHA) 
Konzentration der Gesamtfettsäuren in der erythrozytären Membran. Der Eisenstatus von Frauen im 
gebärfähigen Alter (n = 178) wurde mittels Hämoglobin- (Hb), Ferritin-, löslichem Transferrinrezeptor-
Konzentration (sTfR) und dem sTfR-Ferritin Index bestimmt. 
Ergebnisse: Das Risiko eines Vitamin D Defizits (25(OH)D < 25.0 nmol/l) war bei Schwangeren 3,7x und 
bei Stillenden 4,0x höher als bei Nichtschwangeren und Nichtstillenden, bei denen die Vitamin D 
Versorgung allerdings ebenfalls überwiegend unzureichend war. Der Omega-3 Index war bei Schwangeren 
höher als bei Stillenden (6,40 ± 1,31% vs. 5,50 ± 1,34%). Möglicherweise wiesen 87,1% der Schwangeren 
und Stillenden eine unzureichende Omega-3 Versorgung auf. Der Omega 3 Index lag bei 97,3% der Frauen 
zwischen 40 und 60 Jahren unterhalb von 8%, womit ein erhöhtes Risiko für kardiovaskulär bedingte 
Todesfälle vorliegt. Einen inadäquaten Eisenstatus (Ferritin < 20 µg/l und/oder Hb < 12 g/dl) hatten 16,3% 
der Frauen im gebärfähigen Alter.  
Schlussfolgerung: Der Vitamin D Status sollte bei Schwangeren, Stillenden, aber auch bei 
nichtschwangeren und bei nichtstillenden Frauen derselben Altersklasse, verbessert werden. Zudem ist die 
Festlegung des Vitamin D Status mit dem höchsten gesundheitlichen Nutzen erforderlich. Eine 
ausreichende Omega-3 Versorgung muss bei Frauen im mittleren Alter und möglicherweise auch bei 
Schwangeren und Stillenden sichergestellt werden. Weitere Studien sind notwendig, die den optimalen 
Omega-3 Status während der Schwangerschaft und Stillzeit ermitteln. Für die Verbesserung der 
Versorgung von Vitamin D und den langkettigen Omega-3 Fettsäuren stehen verschiedene Möglichkeiten 
zur Verfügung, dessen Eignung in weiteren Studien untersucht werden muss. Frauen im gebärfähigen Alter 
sollten eine ausreichende Eisenaufnahme sicherstellen, um den Eisenstatus aufrechtzuerhalten. Die 
Aufklärung über die verschiedenen Eisenquellen und deren Verfügbarkeit sind hierfür obligatorisch. 
Studienregistrierung: Deutsches Register Klinischer Studien DRKS00004789  
Stichwörter: Nährstoffstatus, Frauen, Deutschland 
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1. General introduction 
1.1. Nutritional requirements and aim of this dissertation thesis 
As early as over 500 years before Christ, Hippocrates knew that “food be thy medicine and 
the medicine your food”. Nutrition not only ensures the energy supply but is also essential to 
maintaining physical, psychological and metabolic functions and to preventing diet-related 
illnesses. Micronutrients, vitamins and also certain fatty acids (FA) have a special relevance 
to these functions (WHO 1985). Therefore, reference values for the dietary intake are 
recommended to ensure the required supply of nutrients for the majority of healthy people. In 
Germany, the recommendations are established by the German Nutrition Society (Deutsche 
Gesellschaft für Ernährung, DGE) in cooperation with the Austrian Nutrition Society 
(Österreichische Gesellschaft für Ernährung) and the Swiss Society for Nutrition 
(Schweizerische Gesellschaft für Ernährung) (D-A-CH) (D-A-CH 2015). 
For the assessment of the nutrient supply, the dietary intake of food is usually evaluated by 
validated questionnaires such as food frequency questionnaires or food records. Based on 
these data, the nutrient intake is calculated using food composition tables. The resulting 
intake is compared with the dietary intake recommendations of professional societies. 
However, the calculated nutrient intake allows only estimations about the nutrient status 
because of several influencing factors (Elmadfa & Leitzmann 2015). For example, the 
nutrient content in foods are subject to fluctuations (Souci et al. 2015). Moreover, the 
bioavailability of micronutrient is affected by food processing (Platel & Srinivasan 2016) as 
well as absorption-promoting and absorption-inhibiting factors, which is especially relevant to 
the micronutrient iron (Collings et al. 2013). In contrast, the nutrient intake of vitamin D 
contributes only insignificantly to the vitamin D status because the human body can 
synthesize the vitamin D requirement endogenously via ultraviolet B (UVB) radiation 
(Seckmeyer et al. 2013). In addition, the nutrient requirements of women are partially 
dependent on the physiological status (D-A-CH 2015). For example, the maternal nutrient 
status of specific nutrients, such as long-chain (LC) omega-3 (n-3) polyunsaturated fatty 
acids (PUFAs), also provides the fetal and infantile nutrient supply with these nutrients (Gil-
Sanchez et al. 2010; Meldrum et al. 2012). In addition, the status of certain nutrients is 
influenced by the menstruation (Napolitano et al. 2014) and possibly even by hormones 
(Magnusardottir et al. 2009; Pilz et al. 2017). These factors are partly considered in the 
dietary intake recommendations (D-A-CH 2015). Nevertheless, biochemical parameters 
should be analyzed instead of dietary intake to reflect the current nutrient status. The 
biochemical parameters have a high accuracy when assessing the actual nutrient status and 
detect nutrient deficiencies at an early stage. In this respect, the measured biochemical 
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values are compared with the scientific biochemical reference values (Elmadfa & Leitzmann 
2015).  
For Germany, biochemical data on various vitamins and minerals were collected by as early 
as the 1980s as part of the “Nutrition Survey and risk factors analysis” study on 2,000 
subjects (Heseker et al. 1994; Kohlmeier et al. 1995). Newer nationwide data on the nutrient 
supply are available for certain nutrients and partly only for specific population groups, such 
as for LC n-3 PUFAs (Geppert et al. 2005; Kröger et al. 2011) or vitamin D (Hintzpeter et al. 
2008; Weisse et al. 2013; Wuertz et al. 2013; Richter et al. 2014; Jungert & Neuhauser-
Berthold 2015; Rabenberg et al. 2015). Surveys of the nutrient status of women in specific 
stages of life are limited or nonexistent, although this aspect should be assessed due to the 
changing requirements during the lifetime of women. 
 
Study objectives 
To gain knowledge about the nutrient supply situation of women, the status of vitamin D, LC 
n-3 PUFAs and iron was investigated in women with an increased requirement or in certain 
phases of life for which the supply situation is most likely critical. The following issues are the 
basis of this dissertation thesis and are described in the scientific publications (chapter 2): 
1. How does the risk of an inadequate vitamin D status in pregnant women compared to 
non-pregnant women of the same age, region and season of recruiting? (Paper I, chapter 
2.1.1) 
2. Do breastfeeding women have a higher risk of an inadequate vitamin D status than non-
pregnant and non-breastfeeding women of the same age, region and season of 
recruiting? (Paper II, chapter 2.1.2) 
3. How is the status of LC n-3 PUFAs in pregnant and lactating women? (Paper III, chapter 
2.2.1) 
4. Are middle-aged women adequately supplied with LC n-3 PUFAs? (Paper IV, chapter 
2.2.2) 
5. Do women of reproductive age show an adequate iron status, and how do oral 
contraceptives affect the iron status depending on several other influencing factors? 
(Paper V, chapter 2.3) 
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1.2. Vitamin D 
1.2.1. Structure, metabolism and endogenous synthesis 
Structure and metabolism 
The fat-soluble vitamin D derivatives have a secosteroid structure with different substituents 
among the various compounds. One of the important derivatives is vitamin D2 
(ergocalciferol), which is produced by provitamin D2 (ergosterol) in plants. The second is 
vitamin D3, which is formed by provitamin D3 (7-dehydrocholesterol, 7-DHC) in the skin (Bikle 
2014) (Figure 1).  
Vitamin D2 and vitamin D3 are metabolized by the same pathway within the fat absorption 
and metabolism. The absorption rate of vitamin D3 is approximately 78.6% (Thompson et al. 
1966) and increases with the intake of fat during a meal (Dawson-Hughes et al. 2015). 
Vitamin D is released in the liver by the degradation of chylomicrons. Precholecalciferol is 
hydroxylated to calcidiol (25-hydroxyvitamin D = 25(OH)D), which is transported to the kidney 
via vitamin D binding protein (VDBP). The active form of vitamin D – calcitriol (1,25-
dihydroxyvitamin D = 1,25(OH)2D) – is converted by 1α-hydroxylase (1α(OH)ase, CYP27B1). 
For constant concentrations, 25(OH)D and 1,25(OH)2D can be cleaved by 24-hydroxylase 
(24(OH)ase) to calcitroic acid (Bikle 2014). Vitamin D is mainly stored in the fatty tissue 
(Mawer et al. 1972) with a half-life of about two months (Preece et al. 1975; Dlugos et al. 
1995; Vieth 1999). 
 
Endogenous synthesis 
Vitamin D has a special position within the vitamins because vitamin D3 can be synthesized 
endogenously via UVB radiation (290 - 315 nm) (MacLaughlin et al. 1982) (Figure 1). In this 
way, 7-DHC in the skin is cleaved by sunlight to form precholecalciferol, which is 
metabolized. Inactive vitamin D isomers are formed by strong UVB radiation to avoid 
vitamin D intoxication (hypervitaminosis) (Holick 2007).  
The vitamin D requirement can be achieved by endogenous vitamin D synthesis (Seckmeyer 
et al. 2013). However, several conditions influence the conversion rate and therefore the 
vitamin D status. On the one hand, the endogenous synthesis depends on the UVB radiation 
(Bogh et al. 2011) and therefore geo-climate conditions are determinative for the synthesis: 
 Latitude: The availability of UVB radiation declines with higher latitude (O'Neill et al. 2016). 
 Season: It is feasible to synthesize vitamin D in Central Europe during the whole year 
(Seckmeyer et al. 2013). However, in northern latitudes such as Germany, the synthesis is 
limited between October and March (Engelsen et al. 2005) because the UVB radiation for 
the production of vitamin D is considerably lower in the winter months than in the summer 
months (Serrano et al. 2017). For example, three days in December are necessary to 
synthesize adequate vitamin D amount (25 µg [≙1000 international units; conversion factor: 
  General introduction: Vitamin D 
4 
 
40]) in Central Europe, whereas only 18 minutes are required in June (Seckmeyer et al. 
2013).  
 Time of day: The effective solar UVB radiation to produce vitamin D is the highest around 
noon (Serrano et al. 2017). 
 Thick ozone, clouds (Engelsen et al. 2005) and shade reduce the synthesis capacity 
(Turnbull et al. 2005). 
 
Figure 1 Vitamin D metabolism.  
Figure was modified according to Holick 2007 and with addition of Deluca 2011 and Bikle 2014. 
Structural formula of 25(OH)D and 1,25(OH)2D relate to 25(OH)D3 and 1,25(OH)2D3. 
Abbreviations: -, negative influence; +, positive influence; 1,25(OH)2D, 1,25-dihydroxyvitamin D; 
25(OH)D, 25-hydroxyvitamin D; CH2, methylene group; CH3, methyl group; FGF-23, fibroblast growth 
factor-23; HPO4
2-, hydrogenphosphat; OH, hydroxide ion; PTH, parathyroid hormone; UVB, ultraviolet B. 
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Moreover, vitamin D synthesis capacity is negatively affected by personal factors: 
 Non-modifiable factors: increasing skin pigmentation (Webb & Engelsen 2006; Libon et 
al. 2013; Xiang et al. 2015), increasing age (MacLaughlin & Holick 1985; Need et al. 1993) 
and burns (Schumann et al. 2012) 
 Modifiable factors: lower skin area (Osmancevic et al. 2015) and therefore wearing 
clothing (Seckmeyer et al. 2013) with increasing darkness (Matsuoka et al. 1992), vertical 
body posture (Seckmeyer et al. 2013) and the use of sunscreens (Matsuoka et al. 1987) 
 
1.2.2. Function 
The effects of vitamin D are mediated non-genomic and genomic by binding on the vitamin D 
receptor (VDR). Non-genomically, 1,25(OH)2D is bound on the VDR in the caveolae of the 
plasma membrane (Haussler et al. 2011). Genomically, 1,25(OH)2D cooperates with the 
VDR and forms a heterodimer with the retinoid X receptor (RXR). This VDR/RXR complex 
binds to a specific deoxyribonucleic acid region of the genes – the vitamin D response 
element – which leads to the activation or suppression of the transcription (Christakos et al. 
2016). 
 
Skeletal effects  
1,25(OH)2D regulates the calcium and phosphate homeostasis by influencing the intestinal 
calcium absorption (Pansu et al. 1983; Aloia et al. 2014), the intestinal phosphate absorption 
(Rizzoli et al. 1977) and the renal calcium reabsorption (Yamamoto et al. 1984). In the bone, 
1,25(OH)2D affects the bone mineralization as well as the bone resorption and thus effects 
on the calcium and phosphate level. The stimulation of osteoblasts by 1,25(OH)2D results in 
a bone mineralization (Matsumoto et al. 1991). However, 1,25(OH)2D also promotes the 
osteoclastic bone resorption via stimulation of a soluble factor by osteoblasts (McSheehy & 
Chambers 1987). The regulation of the serum calcium levels is also indirectly affected by 
1,25(OH)2D because it suppresses the parathyroid hormone (PTH) (Silver et al. 1986). PTH 
is responsible for the release of bone mineral by osteoclasts (Weisbrode et al. 1978).  
As a result, an inadequate vitamin D status could cause rickets in children (Shaw 2016), 
osteomalacia in adulthood (Bhan et al. 2012) as well as fractures (Brincat et al. 2015; Fu et 
al. 2015), falls (Rothenbacher et al. 2014; Brincat et al. 2015) and secondary 
hyperparathyroidism (Lips 2001). 
 
Extra skeletal effects 
VDR and 1α(OH)ase are also expressed in tissues such as the cardiovascular system (Chen 
et al. 2008), brain (Eyles et al. 2005), colon (Matusiak et al. 2005) and breast (McCarthy et 
al. 2009). Therefore, a probably association of vitamin D with many diseases is conceivable: 
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 Cardiovascular diseases (Anderson et al. 2010; Ford et al. 2014) 
 Diabetes mellitus type 2 (Mitri et al. 2011) and diabetic nephropathy (Derakhshanian et al. 
2015) 
 Inflammatory diseases (Duan et al. 2014; Lin et al. 2016; Sadeghian et al. 2016) 
 Cancer such as colon (Ma et al. 2011; Ying et al. 2015) and breast cancer (Chen et al. 
2010; Kim & Je 2014) 
 All-cause mortality (Garland et al. 2014; Pilz et al. 2016)  
However, the data situation is inconsistent for some of these diseases (James et al. 2013; 
Sperati et al. 2013; Seida et al. 2014; Lugg et al. 2015; Jacobs et al. 2016) and partially 
intervention studies are missing. 
 
Effects during pregnancy and breastfeeding period  
During pregnancy, the maternal vitamin D status is not only important for the mother's health, 
but also for the health of the fetus and infant (Table 1). The fetal and infant vitamin D status 
depends on the maternal vitamin D supply (Wagner et al. 2012). This arrangement is shown 
by having a high correlation of the maternal 25(OH)D concentration – biochemical parameter 
of vitamin D status – with the 25(OH)D concentration of the cord blood (Dror et al. 2011; 
Wuertz et al. 2013; Pena et al. 2015) and breastmilk (við Streym et al. 2016). Moreover, VDR 
is present in the placenta (Pospechova et al. 2009) and even in fetal tissues (Betts et al. 
2015). The maternal vitamin D status also influences the protein expression of 1α(OH)ase in 
the placenta (O'Brien et al. 2014) and the 25(OH)D concentration in the breast milk upon 
delivery (Mohamed et al. 2014).  
During pregnancy, the vitamin D metabolism changes with a two-three times higher 
1,25(OH)2D concentration than in non-pregnant women (Papapetrou 2010; Hollis et al. 
2011). This increase is independent of the rise of VDBP (Bikle et al. 1984). Calcitonin is 
probably responsible for the higher 1,25(OH)2D concentration (Hollis et al. 2011) because it 
controls the 1α(OH)ase activity (Zhong et al. 2009) and is enhanced during pregnancy (Silva 
et al. 1981). It is suggested that at this time the 1,25(OH)2D concentration is disengaged from 
the calcium, phosphorus and PTH metabolism (Hollis et al. 2011). Therefore, the enhanced 
1,25(OH)2D concentration does not result in a hypercalcemia and hypercalciuria (Hollis et al. 
2011). A 25(OH)D concentration of at least 100.0 nmol/L (≙ 40 ng/ml, conversion factor: 
2.496) is needed to ensure an optimal production of 1,25(OH)2D during pregnancy (Hollis et 
al. 2011).  
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Table 1 Influence of vitamin D on the course of pregnancy, development and health of the 
fetus and infant and the mother’s health. 
Influence on the course of pregnancy 
Preterm birth  
 
 Maternal 25(OH)D concentrations > 100.0 nmol/L compared 
with < 50.0 nmol/L are associated with a lower risk for preterm 
birth (< 37th week of gestation) (RR 0.41; 95% CI 0.20, 0.86) 
(Wagner et al. 2016). 
Caesarean section  
 
 Maternal 25(OH)D concentrations < 37.5 nmol/L versus 
≥ 37.5 nmol/L are related with a higher risk (OR 3.84; 95% CI 
1.71, 8.62) (Merewood et al. 2009). 
 The results are inconsistent (Aghajafari et al. 2013). 
Small for gestational 
age infant  
 
 Maternal 25(OH)D concentrations < 37.5 nmol/L versus 
≥ 37.5 nmol/L are associated with a higher risk (OR 1.85; 95% 
CI 1.52, 2.26) (Aghajafari et al. 2013). 
Influence on the development and health of fetus and infant 
Neuropsychological 
development  
 
 Maternal 25(OH)D concentrations > 75.0 nmol/L compared with 
< 50.0 nmol/L result in a higher mental score (ß 2.60; 95% CI 
0.63, 4.56) and psychomotor score (ß 2.32; 95% CI 0.36, 4.28) 
of their infants (11 - 23 months) (Morales et al. 2012a). 
Bone health 
 
 Per 10.0 nmol/L increase of the maternal 25(OH)D 
concentration, the bone mineral content (19.2 g; 95% CI 5.60, 
32.70) and bone mineral density are higher (4.6 mg/cm2; 95% 
CI 0.10, 0.90) (Zhu et al. 2014). 
 Lower maternal and infantile 25(OH)D concentrations in active 
rickets than in healed rickets (Elidrissy 2013). 
Type 1 diabetes 
 
 Vitamin D supplementation – regardless of amount – in infants 
during the first year of life is associated with a lower incidence 
and risk (RR 0.12; 95 % CI 0.03, 0.51) (Hyppönen et al. 2001) 
Allergy 
 
 Possible U-shaped relation (Rueter et al. 2014), but the results 
are inconsistent (Rueter et al. 2014; Papadopoulou et al. 2015).  
Respiratory tract 
infections 
 
 The highest quartile of maternal 25(OH)D concentration versus 
the lowest quartile is related with a lower risk (OR 0.67; 95% CI 
0.50, 0.90) in the offspring of the first year (Morales et al. 
2012b).  
Influence on the maternal health 
Preeclampsia  
 
 Maternal 25(OH)D concentrations < 30.0 nmol/L compared with 
≥ 50.0 nmol/L are associated with a higher risk (OR 2.23; 95% 
CI 1.29, 3.83) (Achkar et al. 2015). 
Postpartum 
depression 
 
 Maternal 25(OH)D concentrations < 47.0 nmol/L versus 
> 70.0 nmol/L are related with a higher risk (OR 2.72; 95% CI 
1.42, 5.22) (Robinson et al. 2014). 
Gestation diabetes 
mellitus 
 
 Maternal 25(OH)D concentrations < 50.0 nmol/L compared with 
≥ 50.0 nmol/L are associated with a higher risk (OR 1.38; 95% 
CI 1.12, 1.70) (Wei et al. 2013).  
Bacterial vaginosis 
 
 Higher risk at a lower maternal 25(OH)D concentration 
(Aghajafari et al. 2013).  
Abbreviations: ß, standardized coefficient; 25(OH)D, 25-hydroxyvitamin D; CI, confidence interval; OR, 
odds ratio; RR, relative risk. 
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During breastfeeding period, prolactin also stimulates 1α(OH)ase (Ajibade et al. 2010). 
Postpartum, the 1,25(OH)2D concentration is higher in breastfeeding women than in bottle-
feeding women, however, lies in a normal range comparable with non-pregnant (NP) and 
non-breastfeeding (NB) women (Carneiro et al. 2010). The vitamin D activity of milk varies 
and is only between 0.125 and 2.0 µg/L (Hollis et al. 1981; Specker et al. 1985; Ala-Houhala 
et al. 1988; Hollis & Wagner 2004; Wagner et al. 2006). Therefore, a daily vitamin D intake of 
10 µg is recommended for infants up to the age of one year (D-A-CH 2015). This estimated 
value is recommended, regardless of the vitamin D intake via breastmilk or formula as well 
as the endogenous synthesis. Nevertheless, a maternal vitamin D supplementation 
(160 µg/day) during breastfeeding period is as effective as an infant supplementation (Hollis 
et al. 2015). 
 
1.2.3. Nutritional requirements, recommendations and supply situation 
Vitamin D intake  
Only a few foods contain vitamin D in relevant amounts. Fatty fish such as smoked eel 
(smoked: 90.0 µg/100 g), herring (25.0 µg/100 g) or salmon (16.0 µg/100 g) contain the 
highest amounts (Souci et al. 2015).  
Recommendation for vitamin D intake is challenging due to the endogenous vitamin D 
synthesis. The D-A-CH society recommends a vitamin D intake of 20 µg/day for adults (from 
15 years up) as well as for pregnant and breastfeeding women (D-A-CH 2015). This 
estimated value is recommended in case of absent endogenous vitamin D synthesis (D-A-
CH 2015) and based on the fact that 20.0 µg/day ensures a sufficient vitamin D status 
(25(OH)D concentration > 50.0 nmol/L) in 90.0 - 95.0% of the population (Cashman et al. 
2008). Corresponding to the German nutrition report, an average vitamin D intake of 1.5 - 
1.7 µg/day is only ingested by women (19 - 35 years) (DGE 2012). Therefore, an excess of 
the tolerable upper intake level (UL) of 100 µg/day (EFSA 2012b) is not expected with food.  
 
Classification of vitamin D status 
For the assessment of the vitamin D status, the 25(OH)D concentration is suitable because it 
includes both – dietary intake and endogenous synthesis of vitamin D (Ross et al. 2011). 
25(OH)D has a half-life of approximately 15 days (Jones et al. 2014). However, there is no 
consistency about the vitamin D status that results in the highest health advantage in the 
general population (Souberbielle et al. 2010; Holick et al. 2011; Ross et al. 2011; Pludowski 
et al. 2013) and also during pregnancy and breastfeeding periods (Wagner et al. 2012; 
Pludowski et al. 2013). A 25(OH)D concentration < 25.0 nmol/L can be classified as 
deficiency for bone health (Zittermann & Gummert 2010). The DGE considers a vitamin D 
status of at least 50.0 nmol/L for bone health (Linseisen et al. 2011). This value is also 
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recommended by the Institute of Medicine to ensure the requirements of 97.5% of the 
population (Ross et al. 2011). However, there is also an evidence that a 25(OH)D 
concentration of ≥ 75.0 nmol/L should be achieved (CPS 2007; Souberbielle et al. 2010; 
Holick et al. 2011; Vieth 2011) (Table 2). 
Table 2 Classification of vitamin D status depending on the 25-hydroxyvitamin D 
concentration. 
25(OH)D 
concentration 
[nmol/L]1 
Biochemical modifications  
< 25.0 Rickets, osteomalacia, calcium malabsorption, severe 
hyperparathyroidism, low 1,25(OH)2D concentrations, muscular 
diseases, death, dysfunction of immune and cardiovascular system? 
25.0 - 49.9 Reduced bone mineral density, impaired muscle function, low 
absorption of calcium, increased PTH concentrations, slightly 
decreased 1,25(OH)2D levels, increased mortality ratio 
50.0 - 74.9 Low bodily stores of vitamin D, slightly increased PTH levels 
≥ 75.0 No disturbance of vitamin D dependent functions, assurance of 
skeletal health, lower risk of fractures and falls, assurances of 
optimal health in case of an increased risk for cancer, 
cardiovascular disease, muscoskeletal disorders, autoimmune 
disorders 
> 125.0 Increased mortality rate ratio 
> 372.0 Hypercalcemia, acute toxicity 
Table was designed in accordance with Melamed et al. 2008; Priemel et al. 2010; Souberbielle et al. 
2010; Zittermann & Gummert 2010; Ross et al. 2011; Vieth 2011. 
Abbreviations: 1,25(OH)2D, 1,25-dihydroxyvitamin D; 25(OH)D, 25-hydroxyvitamin D; PTH, 
parathyroid hormone. 
1 Conversion in ng/ml: divided by 2.496 nmol/L  
 
In addition to the endogenous vitamin D synthesis and the vitamin D intake, the vitamin D 
status is influenced by several factors. The following factors have a negative impact on the 
vitamin D status: 
 Higher body fat mass (Oliai Araghi et al. 2015) and obesity (Tonnesen et al. 2016) 
 Smoking (Shinkov et al. 2015; Tonnesen et al. 2016) 
 Physical inactivity (Daly et al. 2012; Tonnesen et al. 2016) 
 Genetics (Wang et al. 2010) as shown by the vitamin D dependent rickets type 1B 
(Thacher & Levine 2016) 
 Diseases such as inflammatory bowel diseases (Del Pinto et al. 2015), granuloma-forming 
diseases (Adams & Hewison 2012), primary and secondary hyperparathyroidism (Clements 
et al. 1992) and chronic kidney diseases (Oh et al. 2012) 
 Drugs like anti-epileptics, which increase the decomposition of vitamin D (Wang et al. 2013) 
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Supply situation with vitamin D 
An inadequate vitamin D status is common in the general population of Europe as well as in 
pregnant and breastfeeding women. In the general population of Europe, a total of 40.4% 
show 25(OH)D concentrations below 50.0 nmol/L (Cashman et al. 2016), and in Germany, 
the frequency is approximately between 50.8% and 75.0% (Hintzpeter et al. 2008; 
Zittermann et al. 2009; Richter et al. 2014; Rabenberg et al. 2015). Only 17.5% of the 
German women aged 18 - 44 years demonstrate 25(OH)D concentrations ≥ 75.0 nmol/L 
(Rabenberg et al. 2015). 
Information on the vitamin D status for pregnant and breastfeeding women in Germany are 
only available at the end of pregnancy (34th week of pregnancy). 44.4% of these women 
show 25(OH)D levels below 50.0 nmol/L (Weisse et al. 2013). Moreover, another study 
demonstrates that in 77.0% of German women after birth the vitamin D status is below 
50.0 nmol/L (Wuertz et al. 2013). 
 
1.3. Long-chain omega-3 fatty acids 
1.3.1. Structure and metabolism 
Fatty acids consist of a carbon (C) chain and a carboxyl (COOH) group. The chain length, 
number of double bonds and location of the double bond from the end of the methyl are 
characteristic of the fatty acids. The different structures result in the specific functions of the 
fatty acids. The n-3 PUFAs have their first double bond between carbon atoms 3 and 4. The 
most important n-3 PUFAs are α-linoleinic acid (ALA, C18:3n-3) and the LC n-3 PUFAs 
eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3) 
(Bazinet & Laye 2014).  
After the intake from the diet, the LC n-3 PUFAs are emulsified in the stomach and 
transported to the small intestine. Here, the LC n-3 PUFAs are enzymatically cleaved to free 
FAs and 2-monoacylglycerides. Both reach the enterocytes in the form of micelles. A re-
esterification of the n-3 FAs to triacylglycerides (TG) ensues. In chylomicrons, the TGs enter 
the systemic circulation. From there, TGs are transported via blood to the target tissues 
(Schuchardt & Hahn 2013). 
Humans can convert ALA to EPA and DHA by desaturation, elongation and oxidation 
(Figure 2) (Baker et al. 2016). However, the conversion rate is very low (ALA to DHA < 1%) 
(Plourde & Cunnane 2007; Brenna et al. 2009) and several factors influence the necessary 
enzymes for this conversion process: 
 Co-factors such as zinc (Eder & Kirchgessner 1996), iron (Zhou et al. 2011), magnesium 
(Mahfouz & Kummerow 1989), folate and vitamin B12 (Wadhwani et al. 2012) as well as 
vitamin B6 (Tsuge et al. 2000)show a positive impact on the fatty acid desaturase. 
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 Insulin promotes (Arbo et al. 2011) and glucagon suppresses the fatty acid desaturase 
(Rimoldi et al. 2001). 
 Estrogen may enhance the conversion (Burdge & Wootton 2002; Giltay et al. 2004; Kitson 
et al. 2013). 
 Genetic polymorphisms of the elongase (Zhang et al. 2016a) and fatty acid desaturase 
(Horiguchi et al. 2016; Zhang et al. 2016a) inhibit the synthesis. 
 The omega-6 (n-6) PUFA linoleic acid (LA, C18:2n-6) competes for the same conversion 
enzymes and is therefore a limiting factor in the conversion of LC n-3 PUFAs (Portolesi et 
al. 2007) (Figure 2). 
Moreover, a retroconversion of DHA to EPA is possible (Stark & Holub 2004; Plourde et al. 
2011; Park et al. 2016). 
 
 
Figure 2 Biosynthesis of omega-3 fatty acids and omega-6 fatty acids.  
This figure was modified according to Bazinet & Laye 2014 and Baker et al. 2016. 
Abbreviations: C, carbon; COOH, carboxyl group; Elovl2 or 5; elongation of very long-chain fatty acids 
2 or 5; Fads1 or 2, fatty acid desaturase 1or 2; N-3, omega-3; N-6, omega-6. 
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1.3.2. Function 
DHA exists in many organs such as in the brain, retina and testis (Sassa & Kihara 2014). 
Several physiologic effects are associated with the LC n-3 PUFAs (Table 3). Therefore, LC 
n-3 PUFAs have various benefits on the health of the general population (Table 4). However, 
more intervention studies are partly necessary to determine the evidence for these potential 
effects. 
 
Table 3 Physiologic mechanism of long-chain omega-3 fatty acids. 
Mechanism of LC n-3 PUFAs  
Membrane fluidity 
 
 DHA is incorporated in lipid rafts (Schley et al. 2007) and enhances 
their membrane fluidity (Aliche-Djoudi et al. 2013). DHA leads to a 
modification of the fatty acid composition and decreases epidermal 
growth factor receptor in the lipid rafts (Schley et al. 2007). 
Neurite Growth  
 
 LC n-3 PUFAs enhance the neurite outgrowth in adults and aged 
neurons, as shown in sensory neuronal culture of dorsal root ganglia 
from rat (Robson et al. 2010). The effects are the result from the 
incorporation of LC n-3 PUFAs in Apo E containing lipoproteins in 
the form of fatty acid moiety of phospholipids. These lipoproteins 
promote the number of branches and therefore the neurite 
outgrowth (Nakato et al. 2015) 
Synaptogenesis   DHA increases the synaptic transmission (Connor et al. 2012) and 
improves the PSD95 level as well as the expression of 
synaptophysin (Tao et al. 2016) 
Gene expression   LC n-3 PUFAs regulate the expression of several genes, which 
regulate the inflammation, neuronal processes or the fatty acid 
metabolism, such as CD36 (Vedin et al. 2012), RAR, RXRα, RXRß 
(Dyall et al. 2010), PPARα, HNF6 and HNF1ß (Schmidt et al. 2012) 
Neurogenesis   LC n-3 PUFAs improve the number of S-phase cells in the neurons 
(Beltz et al. 2007) and neurogenesis (Beltz et al. 2007; Dyall et al. 
2010)  
Oxylipin 
synthesis 
 LC n-3 PUFAs can be metabolized to oxygenated metabolites 
(oxylipins) by cyclooxygenase, lipoxygenase and cytochrome P450 
pathway (Wang et al. 2014). For example, eicosanoids are formed, 
such as the DHA metabolite 17-HDHA (resolvin D1 precursor) 
(Shearer et al. 2010; Fischer et al. 2014), which has anti-
inflammatory effects (Neuhofer et al. 2013; Erdinest et al. 2014). 
Abbreviations: 17-HDHA, 17-hydroxydocosahexaenoic acid; CD36, cluster of differentiation 36; ApoE, 
Apolipoprotein E; DHA, docosahexaenoic acid; HNF1ß, hepatocyte nuclear factor 1 beta; HNF6, 
hepatocyte nuclear factor 6; LC n-3 PUFAs, long-chain omega-3 polyunsaturated fatty acids; PPARα, 
peroxisome proliferator-activated receptor alpha; PSD95, postsynaptic density protein 95; RAR, 
retinoic acid receptor; RXRα or ß, retinoid X receptor α or ß; S-phase; synthesis phase. 
 
  
 
  
  General introduction: LC n-3 PUFAs 
13 
 
Table 4 Effects of long-chain omega-3 fatty acids on the health in the general population. 
Effects in the general population 
Cardiovascular 
diseases 
 
 Higher LC n-3 PUFAs status is related with a lower incidence of 
elevated blood pressure (RR 0.67; 95% CI 0.55, 0.83) (Yang et 
al. 2016). 
 LC n-3 PUFAs supplementation (≥ 1000 mg/day, ≥ 12 months) 
is associated with a lower risk for cardiac death (RR 0.68; 95% 
CI 0.56, 0.83) and myocardial infarction (RR 0.75; 95% CI 0.63, 
0.88) in patients with cardiac diseases in the past (Casula et al. 
2013). 
 LC n-3 PUFAs supplementation (450 - 4500 mg/day, average 
intake of 56 days) improves the flow-mediated dilation (WMD 
2.3; 95% CI 0.89, 3.72) (Wang et al. 2012). 
Cognitive decline  LC n-3 PUFAs supplementation (400 - 1800 mg/day for 3 - 
40 months) reduces the Mini-Mental State Examination score 
(WMD 0.15; 95% CI 0.05, 0.25) (Zhang et al. 2016b). 
 LC n-3 PUFAs supplementation (2.2 g/day for 26 weeks) 
enhances executive functions and white matter microstructure 
(Witte et al. 2014). 
Depressive symptoms 
 
 Higher n-3 PUFAs intake is related with a reduced risk of 
depressive symptoms (Beydoun et al. 2015). 
 Inverse relation between omega-3 index and depressive 
symptoms in subjects with increased oxidative stress (ß -1.74 ± 
0.88) (Bigornia et al. 2016). 
Breast cancer 
 
 The highest quantile of n-3/n-6 intake (> 0.03 - 14.76 g) versus 
the lowest quantile (< 0.005 - < 5.48 g) is associated with a 
lower risk (RR 0.90; 95% CI 0.82, 0.99) (Yang et al. 2014).  
Bone and the risk of 
fracture 
 
 Intake of 4000 mg/day LC n-3 PUFAs for three months 
decreases bone resorption (Hutchins-Wiese et al. 2014).  
 DHA downregulates the expression of osteoclast-specific genes 
in osteoclasts, as shown in vitro (Kasonga et al. 2015).  
 Inverse association between the total n-3 PUFA status and the 
risk of hip fracture (HR 0.55; 95% CI 0.30, 1.01) (Orchard et al. 
2013). 
Type 2 diabetes 
 
 The omega-3 index is negatively related with the risk in women 
under the age of 70 (Harris et al. 2016). 
 Δ5-desaturase activity is negatively and Δ6-desaturase activity 
is positively associated with the risk (Harris et al. 2016). 
 The evidence is inconclusive (Wu et al. 2012; Zhang et al. 2013).  
Rheumatoid arthritis  Long-term LC n-3 PUFAs intake of > 210 mg/day is associated 
with a lower risk (RR 0.48; 95% CI 0.33, 0.71) (Di Giuseppe et 
al. 2014).  
All-cause mortality  
 
 Each 300 mg/day increase of LC n-3 PUFAs intake reduces the 
risk (RR 0.94; 95% CI 0.89, 0.99) (Chen et al. 2016). 
Abbreviations: ß, standardized coefficient; CI, confidence interval; DHA, docosahexaenoic acid; HR, 
hazard ratio; LC n-3 PUFAs, long-chain omega-3 fatty polyunsaturated acids; N-3, omega-3; N-6, 
omega-6; Omega-3 index, relative eicosapentaenoic acid and docosahexaenoic acid concentration in 
relation to total fatty acids in erythrocyte membranes; RR, relative risk; WMD, weighted mean 
difference.  
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Effects during the pregnancy and breastfeeding period 
LC n-3 PUFAs, and especially DHA, have a particular importance during the pregnancy and 
breastfeeding period (Table 5). In addition to the n-6 PUFA arachidonic acid (AA, 20:4n-6), 
DHA influences the visual and cognitive development (Koletzko et al. 2008). High rates of 
DHA accumulate in the fetal brain, liver and retina during late pregnancy, which continues in 
the infant brain until the second year of life (Martinez 1992). 
Usually, the fetus (Chambaz et al. 1985; Rodriguez et al. 1998), placenta (Cho et al. 1999) 
and infant (Carnielli et al. 2007) can synthesize DHA. However, the fetus and infant are also 
supplied by the maternal LC n-3 PUFA status via transfer by the placenta (Gil-Sanchez et al. 
2010) or breast milk (Meldrum et al. 2012). An average of 40 mg DHA in the last weeks of 
pregnancy (Kuipers et al. 2012) and approximately 110 mg DHA during breastfeeding period 
(Kent et al. 2006; Brenna et al. 2007; Brenna & Lapillonne 2009) are transferred every day to 
the fetus and an exclusively breastfed infant, respectively.  
Physiological changes may be covered the additional maternal requirement. Pregnant rats 
show a higher activity of the Δ6-destaurase and DHA concentration than non-pregnant rats 
(Kitson 2013). It is suggested that the higher Δ6-desaturase activity results by estrogen 
(Kitson 2013), whose concentration increases during pregnancy (Schock et al. 2016). 
However, the positive effect of estrogen on the conversion rate during pregnancy may no 
longer exist during the breastfeeding period (Burdge 2004) because the estrogen 
concentration decreases postpartum (Rasmussen & Kjolhede 2004). 
 
1.3.3. Nutritional requirements, recommendations and supply situation 
N-3 PUFA and n-6 PUFA intake 
National dietary reference recommendations of n-3 PUFAs for the German healthy 
population exist only for the essential FA ALA as EPA and DHA can convert from ALA. The 
recommended intake of ALA should be sufficient to ensure an adequate LC n-3 PUFA supply 
(D-A-CH 2015).  
ALA is found in different oils such as soya, walnut, rapeseed, linseed or pumpkin seed 
(Souci et al. 2015). An ALA intake of 0.5% of the energy intake is recommended for women, 
which is approximately 0.9 - 1.7 g/day (D-A-CH 2015). Data of the German nutrition report 
2012 show that the average intake of ALA is 1.0 g/day in women (15 - 80 years) (DGE 2012).  
Fish such as herring, salmon, sardine and mackerel are the primary food sources for EPA 
and DHA (Souci et al. 2015). In addition, micro algae (Ryckebosch et al. 2014) and Antarctic 
krill (Gigliotti et al. 2011) are also LC n-3 PUFAs sources. In contrast to Germany, an 
additional recommendation intake of EPA and DHA is suggested from other authoritative  
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Table 5 Effects of long-chain omega-3 fatty acids on the course of pregnancy, development 
and health of the fetus and infant and the mother’s health. 
Effects on the course of pregnancy and development and health of the fetus and infant 
Preterm birth 
 
 Per 1% increase of the relative DHA level, the gestational age is 
1.6 day longer (Harris et al. 2015). 
 LC n-3 PUFAs supplementation (> 100 mg/day, ~second trimester 
until end of gestation) is related with a lower risk of early preterm 
birth (< 34th week of gestation) (RR 0.74; 95% CI 0.82, 1.01) 
(Imhoff-Kunsch et al. 2012). 
Birth outcome 
 
 Maternal supplementation of 600 mg DHA/day during pregnancy is 
associated with an increase of birth weight (172 g) and head 
circumference (0.5 cm) (Carlson et al. 2013). 
 Maternal supplementation of 600 mg DHA/day from the 20th week 
of gestation until delivery is associated with an increase of the 
gestational length of about 4.0 - 4.5 days (Harris et al. 2015). 
 The results are inconsistent (Delgado-Noguera et al. 2015). 
Cognitive and visual 
development  
 Positive association between the cord DHA level and the visual 
function (Jacques et al. 2011), memory function (Boucher et al. 
2011), motor function (Bakker et al. 2009) and neurological 
development (Jong et al. 2015). 
 Maternal seafood intake ≤ 340 g/week versus > 340 g/week during 
pregnancy is related with a higher risk of a low verbal intelligence 
quotient in children between 6th month and 8th year of life (OR 
1.09; 95% CI 0.92, 1.29) (Hibbeln et al. 2007). 
Immune system  Maternal supplementation of 400 mg DHA/day from the 18th - 22th 
week of gestation until delivery reduces the incidence of colds (OR 
0.76; 95% CI 0.58, 1.00) and results in a shorter duration of cough, 
phlegm and wheezing during the infant’s first month of life (Imhoff-
Kunsch et al. 2011). 
Asthma and allergy 
 
 Maternal LC n-3 PUFAs supplementation during pregnancy is 
associated with a lower risk of childhood asthma (OR 0.35; 95% CI 
0.15, 0.79) (Klemens et al. 2011). 
 LC n-3 PUFAs supplementation is related with a lower risk of 
allergy in infants between the age of 12 - 36 months (OR 0.66; 
95 % CI 0.44, 0.98) (Gunaratne et al. 2015). 
 The evidence is inconclusive (Best et al. 2016).  
Blood pressure 
 
 Higher maternal LC n-3 PUFAs status during the second trimester 
shows a lower childhood systolic blood pressure at the age of 6 
year (ß -0.28; 95% CI -0.54, -0.03) (Vidakovic et al. 2015).  
Influence on maternal health 
Postpartum 
depression  
 Lower maternal omega-3 index in the 28th week of pregnancy is 
associated with a higher occurrence of depressive symptoms 
(ß 0.39; p < 0.01) (Markhus et al. 2013). 
 Lower n-3 PUFAs and DHA levels in women with postpartum 
depression (Vriese et al. 2003).  
 Higher DHA concentration in breastmilk is related with a lower 
prevalence of postpartum depression (Hibbeln 2002). 
Abbreviations: ß, standardized coefficient; CI, confidence interval; DHA, docosahexaenoic acid; LC n-
3 PUFAs, long-chain omega-3 polyunsaturated fatty acids; N-3 PUFA, omega-3; OR, odds ratio; 
omega-3 index, relative eicosapentaenoic acid and docosahexaenoic acid concentration in relation to 
total fatty acids in erythrocyte membranes; P, probability; RR, relative risk.  
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bodies and expert scientific organizations, which range from 250 to 500 mg/day for the 
general population, which are partly recommended for the prevention of cardiovascular 
diseases (ISSFAL 2004; Kris-Etherton et al. 2007; EFSA 2010; DeSalvo et al. 2016). For 
pregnant and breastfeeding women, the D-A-CH society recommends 200 mg DHA/day (D-
A-CH 2015). The daily intake in German women is an average of 58 mg of EPA and 107 mg 
of DHA (DGE 2012). Moreover, an average of 105 g fish/week is ingested (DGE 2012) in 
contrast to the recommended intake of 150 - 220 g/week (Oberritter et al. 2013). 
An UL does not exist for DHA and EPA due to insufficient data (EFSA 2012a). 
The intake of LC n-6 PUFAs is also crucial for the assessment of the LC n-3 PUFA status 
due to the same conversion enzymes (Portolesi et al. 2007). A specific ratio for the intake of 
n-3/n-6 is not justifiable (EFSA 2010). National dietary reference value for the ALA intake 
does not exist. A LA intake of 2.5% of the energy intake (4.7 - 8.6 µg/day) is assumed to be 
sufficient for an adequate AA synthesis (D-A-CH 2015). Meat and fatty fish contain high 
amounts of LA and AA . Moreover, LA is found in different oils, such as sunflower (Souci et 
al. 2015). In German women (15 - 80 years), the average daily intake of LA is 7.3 g and that 
of AA is 128 g (DGE 2012). 
 
Classification of LC n-3 PUFA status 
A biochemical measurement of LC n-3 PUFAs reflects the total LC n-3 PUFA status – 
synthesized and ingested EPA and DHA (Tu et al. 2013). The analysis in the erythrocyte 
membranes reflects the long-term status of LC n-3 PUFAs (Harris & Schacky 2004; Sun et 
al. 2007). The investigation of the omega-3 index comprises the relative EPA and DHA 
concentration in relation to the total fatty acids in erythrocyte membranes (Harris & Schacky 
2004). The categorization of the omega-3 index is shown in Table 6. Originally, the omega-3 
index was used in the cardiology field in which the risk of death from coronary heart disease 
is the lowest at an omega-3 index of ≥ 8% and the highest risk at an omega-3 index of ≤ 4% 
(Harris & Schacky 2004). For pregnant and breastfeeding women, no biochemical reference 
values are available. However, an omega-3 index ≤ 5% during pregnancy is probably a risk 
factor for postpartum depression (Markhus et al. 2013). 
 
Table 6 Classification of long-chain omega-3 fatty acids by the omega-3 index.  
Classification Omega-3 index (%) 
Very low  ≤ 4 
Low > 4 - 6 
Moderate > 6 - 8 
High > 8 
Table was designed in accordance with the classification of Stark et al. 2016. 
Abbreviation: Omega-3 index, relative eicosapentaenoic acid and docosahexaenoic acid concentration 
in relation to the total fatty acids in erythrocyte membrane. 
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The status of LC n-3 PUFAs depends on several factor values and is negatively affected, for 
example, by smoking (Scaglia et al. 2016; Zaparoli et al. 2016) and positively affected by age 
(Harris et al. 2013) and physical capacity (Moyers et al. 2011). 
 
Supply situation with LC n-3 PUFAs 
The LC n-3 PUFA status is very low or low in the most parts of the world (Stark et al. 2016). 
Extrapolated data of the general German population also show a low LC n-3 PUFA status 
(Stark et al. 2016). However, these data are partially based on studies with a small sample 
size (n ≤ 166), include both genders with an average of 50 years or specific groups, such as 
vegetarian subjects (Geppert et al. 2005; Dawczynski et al. 2010; Baghai et al. 2011).  
National information on the LC n-3 PUFA status do not exist for pregnant and 
breastfeeding women. Studies from other countries like Norway show an average EPA 
level of 0.8 ± 0.1% and an average DHA level of 6.0 ± 0.3% in pregnant women at the 28th of 
gestation (Markhus et al. 2015). Moreover, Norwegian breastfeeding women, who breastfed 
since six months, demonstrate an average EPA level of 0.9 ± 0.1% and an average DHA 
level of 5.9 ± 0.3% (Markhus et al. 2015). 
 
1.4. Iron 
1.4.1. Structure and metabolism 
The micronutrient iron occurs heme-bound (bivalent iron, ferrous, Fe2+) as part of the red 
blood cell hemoglobin (Hb) and the muscle protein myoglobin as well as nonheme-bound 
(trivalent iron, ferric Fe3+) (Steinbicker & Muckenthaler 2013).  
Iron is metabolized primarily in the duodenum (Munoz et al. 2011) (Figure 3). In contrast to 
heme-bound iron, the nonheme-bound iron form is not soluble in its oxidized form (Gulec et 
al. 2014) and must be reduced to Fe2+ before absorption (Steinbicker & Muckenthaler 2013). 
In the enterocytes, heme oxygenase-1 (HO-1) releases iron from heme (Munoz et al. 2011). 
Here, Fe2+ is stored as ferritin or is released into the blood plasma.  
The absorption of Fe2+ in blood plasma is regulated by hepcidin, which influences the 
expression of the necessary iron exporter ferroportin 1 (FPN1) (Steinbicker & Muckenthaler 
2013). In the blood plasma, iron is transported via transferrin. Iron is absorbed in the target 
cells by transferrin receptor (TfR) 1 or 2 or divalent metal transporter 1 (DMT1). There, it is 
either directly needed or is stored as ferritin in the cytosol or as hemosiderin in the 
lysosomes (Munoz et al. 2011).  
The majority of iron (~ 65.0%) is present as Hb in the erythrocytes. The iron requirements for 
the de novo synthesis of Hb (erythropoiesis) in the bone marrow (20 - 30 mg/day) (Munoz 
et al. 2011) is primarily achieved by iron recycling. Erythrocytes are reprocessed in macro- 
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Figure 3 Iron metabolism. 
Figure was modified according to Munoz et al. 2011; Steinbicker & Muckenthaler 2013, Gulec et al. 
2014 and with addition of Neuvonen et al. 1975; O'Neil-Cutting & Crosby 1986; Hallberg et al. 1991; 
Skikne & Cook 1992; Petry et al. 2010; Yang et al. 2012; Collings et al. 2013; Heeney & Finberg 2014; 
Cepeda-Lopez et al. 2015; Freeman 2015; Weinborn et al. 2015; Olivares et al. 2016. 
Abbreviations: BMI, body mass index; DMT1, divalent metal transporter 1; DCYTB, duodenal 
cytochrome B; Fe2+, bivalent iron; Fe3+, trivalent iron; FPN1, ferroportin 1; H+, hydrogen ion; HCP1, 
heme carrier protein 1; HEPH, hephaestin; HIF-2, hypoxia inducible factor-2; HO-1, heme oxygenase-
1; IRP, iron regulatory protein; K+, potassium ion; Na+, sodium ion; NHE, sodium-hydrogen exchanger; 
RES, reticuloendothelial system. 
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phages at approximately 120 days. Therefore, the iron intake by food is principally needed to 
replenish the daily loss of iron (1 - 2 mg/day) through urinary excretion, sweating, blood and 
skin desquamation (Steinbicker & Muckenthaler 2013). 
 
1.4.2. Function 
Iron is important for the supply of oxygen and cellular energy. Moreover, iron influences the 
deoxyribonucleic acid synthesis, cellular proliferation and differentiation as well as the gene 
expression. As a component of different enzymes, such as oxidases, catalases and 
peroxidases, iron is involved in the antioxidative defense (Ekmekcioglu & Marktl 2006). 
The great relevance of iron for health becomes obvious in the negative effects on health in 
the case of an inadequate iron status (Figure 4). Initially, unspecific symptoms appear like 
fatigue (Brutsaert et al. 2003; Krayenbuehl et al. 2011), hair loss (Deloche et al. 2007), 
2007), depression, lack of concentration and irritability (Rangan et al. 1998). With a 
progressive imbalance, the endurance capacity (Brownlie et al. 2004) and the cognitive 
planning ability (Murray-Kolb & Beard 2007; Blanton et al. 2013) are also impaired. 
Moreover, restless leg syndrome occurs, which leads to sleep disturbance and its 
consequences (Allen et al. 2013). 
Iron has also beneficial effects during pregnancy, and its inadequate status is negatively 
associated with maternal and infantile health as well as with the course of pregnancy 
(Breymann 2015; Pratt & Khan 2016; Rahman et al. 2016).  
In contrast to these positive effects, iron also catalyzes the formation of hydroxyl radical 
(Kehrer 2000). An iron overload could lead to oxidative stress or lipid peroxidation, which 
may result in organ damage, such as of the liver (Sengsuk et al. 2014) or brain (Piloni et al. 
2013).  
 
1.4.3. Nutritional requirements, recommendations and supply status 
The assurance of iron requirement is rather complex as numerous factors affect the iron 
status: 
 Iron absorption has a large variation (0.7 - 22.9%) (Collings et al. 2013) due to several 
factors that influence the iron absorption rate (Collings et al. 2013; Cepeda-Lopez et al. 
2015) (Figure 3). The average iron absorption is assumed to be approximately 15.5% 
(Armah et al. 2015). Thereby, the absorption of heme iron is higher (~ 20.0%) (Bezwoda et 
al. 1983) than that of nonheme iron (~ 5.6%) (Armah et al. 2015) caused by the numerous 
factors that influence the nonheme iron absorption (cf. Figure 3).  
 Blood losses through blood donation (Rigas et al. 2014) or gastrointestinal bleeding 
adversely impact the iron status (Reyes et al. 1999). 
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 Menstruation-related blood losses are a determining factor in the iron status of 
premenopausal women. Thereby, an average of 17.6 ml blood is lost during a menstruation 
cycle with an iron loss of approximately 0.43 mg/day (Harvey et al. 2005).  
 Use of contraceptives appears to be a relevant factor on the menstruation-related blood 
losses, and therefore, it is a factor of the iron status: 
 Use of hormonal oral contraceptives (OC) is associated with shorter bleedings time 
(Milman et al. 1998) and less blood loss (Fraser et al. 2012). The use of OCs may be 
positively associated with the iron status (Milman et al. 1998; Miller 2014; Haile et al. 
2016), however, the effect is inconclusive (Casabellata et al. 2007).  
 Use of levonorgestrel intrauterine systems (LNG-IUS) is indicated to improve the Hb 
(Rana et al. 2012; Lowe & Prata 2013) and ferritin concentration (Rana et al. 2012) 
possibly because the use is associated with a decrease in the severity of dysmenorrhea 
(Lindh & Milsom 2013) and menstrual duration (Rana et al. 2012).  
 Use of copper intrauterine device (IUD) results in a decrease of the Hb (Lowe & Prata 
2013) and ferritin concentration (Rana et al. 2012).  
 
Iron intake 
A high iron content is found in meat (especially in offal), wheat bran, millet, soya and quinoa 
(Souci et al. 2015). In animal sources, non-heme and heme-bound iron are available, 
whereas in plant sources exist nonheme-bound iron (Hurrell & Egli 2010). The reference 
value for the iron intake of women considers an iron absorption rate of 10.0 - 15.0% and the 
physiological status (menstruating/non-menstruating) (D-A-CH 2015). According to the 
German nutrition report of 2012, the average intake of iron in women lies below the iron 
recommendation of 15.0 mg/day in menstruating women. In women 19 - 25 years of age the 
average iron intake is 8.6 mg/day, and in women aged 25 - 34 years it is 9.5 mg/day (DGE 
2012). 
An UL does not exist for iron; originated from missing evidence of an association between 
iron status and chronic diseases (EFSA 2006). 
 
Classification of iron status 
Different blood parameters should be taken into consideration to evaluate the iron status 
because the iron content is distributed (Figure 3). The classification is shown in Figure 4. 
Ferritin is an indicator of iron stores (Skikne et al. 1990) and its level already decreases at 
the beginning of an inadequate iron balance (Clark 2008). A sustained imbalance might 
result in a restricted erythropoiesis (iron deficient-erythropoiesis) (Clark 2008). At this time, 
the soluble TfR (sTfR) increases (Flowers et al. 1989). Moreover, sTfR also reflects the 
tissue iron deficiency (Skikne et al. 1990). The analysis of the sTfR-ferritin (sTfR-F) index 
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(sTfR/log10 ferritin) specifies the iron depletion as it combines ferritin and sTfR (Punnonen et 
al. 1997). A progressive iron deficiency leads to a manifestation of anemia with a 
modification of the erythrocytes – microcytic and hypochromic (Clark 2008). Consequently, 
the Hb concentration is decreased, which is an indicator of anemia (WHO 2001). In addition, 
several other forms of anemia exist, such as the megaloblastic anemia with decreased levels 
of vitamin B12 and folate (Yadav et al. 2016). 
In contrast, a severe risk of iron overload exists at a ferritin concentration of > 150 µg/L 
(WHO 2001). 
 
Figure 4 Classification of iron status and health consequences. 
Figure was modified according to Suominen et al. 1998 and with addition of WHO 2001 and Brutsaert 
et al. 2003 3. 
Abbreviations: sTfR, soluble transferrin receptor; sTfR-F index, soluble transferrin receptor-ferritin 
index; ID, iron deficiency non-anemic; IDE, iron-deficient erythropoiesis; IDA, iron-deficiency anemia. 
1 The reference values relate to the recommendations for women; 2 reference value depends on the 
measurement method and therefore corresponds to the value of laboratory (Siemens Healthcare 
Diagnostics Products GmbH 2011); 3 calculated by sTfR/log10 ferritin iron (Punnonen et al. 1997). 
 
Supply situation with iron 
Iron stores are lower in premenopausal women than in men (Dainty et al. 2014). The 
prevalence of iron deficiency in non-pregnant women (< 50 years) of different countries 
varies between 9.7% and 43.0% (Milman et al. 1998; Lahti-Koski et al. 2003; Pynaert et al. 
2007; Miller 2014; Fonseca et al. 2016). Anemia (Hb < 12 µg/L) exists in 22.0% of the 
European non-pregnant women (15 - 49 years) (Stevens et al. 2013). 
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2. Scientific publications 
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2.1.1. Paper I: Higher prevalence of vitamin D deficiency in German pregnant women 
compared with non-pregnant women 
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3. General discussion 
The aim of this dissertation thesis was to assess the vitamin D, LC n-3 PUFA and iron status 
for the first time in German women during a specific lifetime. The collection was confirmed in 
the framework of the nationwide cross-sectional “vitamin and mineral status among German 
women” (VitaMinFemin) study, which investigated the status of selected nutrients that have a 
special relevance to certain life phases of women. According to the results of the nationwide 
survey “National Nutrition Survey II (2008)“ of the Federal Research Institute of Nutrition and 
Food (MRI 2008), those nutrients were determined for which the supply status is suspected 
to be marginal or inadequate. A total of 2367 women (18 - 66 years of age) were recruited 
between April 2013 and March 2015 by 125 general practitioners and gynecologists. The 
necessary blood samples were collected during a routine or diagnostically relevant 
examination. Moreover, nutrient-related aspects, that are required for the assessment of the 
nutrient status, were also evaluated. 
The results of this dissertation thesis are presented in the associated scientific publications 
(chapter 2). 
The supply situation of vitamin D in pregnant (n = 429) and breastfeeding women (n = 
124) in comparison with the status of NP and NB women of the same age, region and 
recruited season are shown in Papers I and II (chapter 2.1).  
The LC n-3 PUFA status was assessed in pregnant women in the third trimester (n = 
213), breastfeeding women (n = 127) and middle-aged women (40 - 60 years) (n = 446). 
The results are discussed in Papers III and IV (chapter 2.2). 
In women of reproductive age (n = 178, 18 - 34 years), the iron status was determined 
with consideration of OCs and several other potential factors (Paper V, chapter 2.3). 
In the following section, the results of this nutrient survey are discussed and compared with 
previous studies.  
 
3.1. Vitamin D status in pregnant and breastfeeding women compared to non-pregnant 
and non-breastfeeding women (Papers I and II) 
The status of vitamin D is inadequate in the general population of Germany as shown in 
previous studies (Hintzpeter et al. 2008; Richter et al. 2014; Rabenberg et al. 2015) and in 
these NPNB women. Approximately 56.0% of these NPNB women demonstrated 25(OH)D 
levels that were below 50.0 nmol/L and only around 12.0% showed a vitamin D status 
≥ 75.0 nmol/L (Paper I and II). This finding could be linked to the fact that only a few foods 
contain appreciable vitamin D contents (Souci et al. 2015). Moreover, even if the 
endogenous vitamin D synthesis could supply an adequate vitamin D amount (Seckmeyer et 
al. 2013), 30% of the women avoid midday sun for sun protection (Gavin et al. 2012), where 
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the synthesis rate is the most effective (Serrano et al. 2017). Additionally, 56% of German 
women use sunscreens (Richter et al. 2014), which reduce the formation (Matsuoka et al. 
1987). 
Therefore, there is the assumption that pregnant and breastfeeding women are also 
inadequately supplied with vitamin D, however, nationwide data are missing. During 
pregnancy and breastfeeding periods, the supply of vitamin D is important for the course of 
pregnancy, the development and health of the fetus (Aghajafari et al. 2013) and infant (Zhu 
et al. 2014) as well as for maternal health (Achkar et al. 2015; Lu et al. 2016). 
 
Main results and assessments compared with previous studies 
These are the first data of the vitamin D status in German women at different points of 
pregnancy (Paper I) and breastfeeding periods (Paper II). 
 The majority of women demonstrated 25(OH)D concentrations below 50.0 nmol/L 
(pregnant women: 78.1%; breastfeeding women: 75.8%). 
 Vitamin D status ≥ 75.0 nmol/L was only present in 4.9 % of the pregnant women and 
5.6 % of the breastfeeding women.  
 A total of 36.8% of the pregnant women showed 25(OH)D concentrations below 
25.0 nmol/L (vitamin D deficiency) and the risk of this level was significantly 3.7-fold 
higher (95% confidence interval [CI] 2.5, 5.4) than in NPNB women in an adjusted model 
(season, region [longitude] of recruiting, recent holidays, age, body mass index [BMI] and 
trimester). 
 In breastfeeding women, a total of 26.6% of the women showed 25(OH)D concentrations 
below < 25.0 nmol/L (vitamin D deficiency) and the risk for this level was significantly 
4.0 times higher (95% CI 1.8, 8.7) than in NPNB women in an adjusted model (season, 
region [longitude] of recruiting and BMI). 
 None of the pregnant and breastfeeding women had 25(OH)D concentrations 
≥ 125.0 nmol/L. 
The high prevalence of an inadequate vitamin D status has also been shown in a previous 
monocentric study of German women after delivery (77.0% < 50.0 nmol/L) (Wuertz et al. 
2013). Moreover, the prevalence of 25(OH)D concentrations below 50.0 nmol/L in pregnant 
or breastfeeding women was equal or even higher in other European countries, such as in 
Ireland (80.0%) (Zhang et al. 2014), the United Kingdom (95.0%) (Jones et al. 2016), Italy 
(70.6%) (Cadario et al. 2015) and Poland (91.9%) (Czech-Kowalska et al. 2015). 
Consistently, Holmes et al. (2009) also showed a higher prevalence of insufficient vitamin D 
status in pregnant women in the United Kingdom compared with NP women (75.0% vs. 
42.0%). 
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Possible explanations for the lower vitamin D status during pregnancy and 
breastfeeding period 
The lower vitamin D status of pregnant and breastfeeding women compared to NPNB 
women in this study could be caused by the additional nutritional requirement of the fetus via 
placenta (Olmos et al. 2016) and infant via breastmilk (Narchi et al. 2010). Moreover, it is 
expected that pregnancies often start with an inadequate vitamin D status – 60.7% of the 
women of childbearing age show 25(OH)D concentrations below 50.0 nmol/L (Pilz et al. 
2017). Interestingly, the risk of a vitamin D status < 25.0 nmol/L was significantly lower (odds 
ratio 0.5; 95% CI 0.3, 0.9) in breastfeeding women than in pregnant women in an adjusted 
model (season and region [longitude] of recruiting). However, previously data demonstrated 
a decrease of the 25(OH)D concentration from pregnancy to breastfeeding period (Jones et 
al. 2016). It is certainly conceivable that the intensity of breastfeeding had an influence on 
the maternal vitamin D status. Narchi et al. (2010) indicated that the prevalence of an 
inadequate vitamin D status in breastfeeding women six month postpartum is slightly higher 
in exclusively breastfeeding women compared to partially breastfeeding women (Narchi et al. 
2010). Therefore, a lower intensity of breastfeeding in this breastfeeding women might be the 
reason for the lower risk of vitamin D status < 25.0 nmol/L, but information about the intensity 
of breastfeeding were not collected in this study. 
 
Influencing factors on the vitamin D status 
Some of the previous studies of pregnant and breastfeeding women showed a similar 
prevalence of an inadequate vitamin D status, however, other European studies like 
Denmark, Sweden or Spain also demonstrated an insufficient vitamin D status but with a 
lower prevalence (18.0 - 44.4%) (Milman et al. 2012; Brembeck et al. 2015; Rodriguez et al. 
2016). Interestingly, a European-wide comparison of the general population showed a higher 
prevalence of vitamin D deficiency in Germany and other mid-latitude countries (Cashman & 
Kiely 2016). Differences in the prevalence may be caused by factors that influence the 
endogenous vitamin D synthesis and, therefore, the vitamin D status. Some of them were 
determined in this study: 
 Season was associated with vitamin D status in both pregnant and breastfeeding 
women in an adjusted model (factors see above), as previously shown in pregnant women 
(Vandevijvere et al. 2012; Rodriguez et al. 2016), breastfeeding women (Czech-Kowalska 
et al. 2015) and the general population (Richter et al. 2014; Rabenberg et al. 2015). The 
risk of 25(OH)D concentrations below 25.0 nmol/L in pregnant and breastfeeding women 
was lower in the summer (June - August) and autumn (September - November) months. 
This result may be originated from the limited endogenous synthesis in Germany during 
October and March (Engelsen et al. 2005). However, even in the summer months, when 
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sufficient vitamin D synthesis is feasible (Seckmeyer et al. 2013), 25(OH)D concentrations 
below 50.0 nmol/L were prevalent in approximately 64.0% of the pregnant and 
breastfeeding women. 
 Higher longitude of recruiting, but not latitude, was related to a lower risk of 25(OH)D 
concentrations below 25.0 nmol/L in pregnant and breastfeeding women (even after 
adjustment: factors see above). However, previously results in Germany indicated that a 
lower latitude have a positive effect on the vitamin D status (Rabenberg et al. 2015) due to 
a higher UVB radiation availability in lower latitudes (O'Neill et al. 2016). The influence of 
longitude in this study may be explained by regional differences in the sunshine duration. 
Based on collected data of the German Meteorological Service (DWD 2013-2015), own 
calculations showed that the sunshine duration is higher in East Germany (higher 
longitude) than in West Germany (lower longitude). 
 
Various other determinants may be also responsible for the higher prevalence of an 
inadequate vitamin D status in this study compared with other studies of European pregnant 
and breastfeeding women: 
 Vitamin D intake and prevalence of supplementation and fortification: This study did 
not analyzed the dietary intake. However, in the general population, the vitamin D intake of 
German women is lower in comparison to other countries like Sweden (1.5 - 1.7 µg/day 
versus 6.7 µg/day) (DGE 2012; Brembeck et al. 2015). Besides, none of this study 
population supplemented vitamin D and only 6.5% of the German women in the general 
population take vitamin D supplements (average intake of 3.5 µg/day) (DGE 2012). In 
contrast, for example in Swedish breastfeeding women the prevalence of vitamin D 
supplementation is higher (31.0%) and also the resulting intake (average intake of 
7.0 µg/day) (Brembeck et al. 2015). Moreover, there is no general vitamin D fortification in 
Germany thus far, even though it is authorized, whereas Sweden as well as other countries 
fortify certain foods with vitamin D (EC 2006). 
 Measurement method of the 25(OH)D concentration also influences the vitamin D status 
(Koning et al. 2013). The prevalence of a sufficient vitamin D status could be higher than 
detected in this study due to the measurement of the 25(OH)D concentration by 
chemiluminescence immunoassay. This methodology underestimates the vitamin D status 
in comparison with the liquid chromatography-mass spectrometry method (Koning et al. 
2013). However, the relative difference between the two measurement methods is 
uncertain (Cashman et al. 2016). Moreover, this circumstance affects all of the analyses 
and therefore does not influence the general result that pregnant and breastfeeding women 
had a lower vitamin D status compared with NPNB women. 
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Owing to the different factors that have an impact on the vitamin D status, the assessment of 
the vitamin D status is very complex. The influence of several other factors, such as recent 
holidays (Richter et al. 2014) or skin type (Webb & Engelsen 2006), were also determined in 
this study. However, no influence was detected. Moreover, other factors cannot be quantified 
in detail, for example, the residence outside, where time of day is important (Serrano et al. 
2017). 
 
3.2. Long-chain omega-3 fatty acid status in pregnant, breastfeeding and middle-aged 
women (Papers III and IV) 
During pregnancy and breastfeeding period, LC n-3 PUFAs are essential, especially for the 
cognitive and visual development of the fetus and infant (Koletzko et al. 2008) and to reduce 
the risk of maternal postpartum depression (Markhus et al. 2013). 
Moreover, several other positive effects are attributed to LC n-3 PUFAs, i.e., on the 
prevention of death from cardiovascular diseases (Harris & Schacky 2004), which is relevant 
due to the increasing prevalence of cardiovascular diseases in this age range (Mozaffarian et 
al. 2015). 
 
Pregnant and breastfeeding women (Paper III) 
 The average DHA level was 5.64 ± 1.43% and the omega-3 index was 6.23 ± 1.48%. For 
pregnant and breastfeeding women exist no omega-3 index reference values. There is an 
evidence that the risk for maternal postpartum depression is increased at an omega-3 
index of ≤ 5% (Markhus et al. 2013), which was present in 22.1% of these women. 
According to the classification of the LC n-3 PUFA status for the generally healthy 
population (Stark et al. 2016), a total of 87.1% of the pregnant and breastfeeding women 
had omega-3 index values below 8%.  
 The DHA level and omega-3 index were significantly higher in pregnant women than in 
breastfeeding women (DHA level: 6.10 ± 1.29% vs. 4.86 ± 1.31%; omega-3 index: 6.62 ± 
1.39% vs. 5.57 ± 1.39%) and were negatively associated with the gestation week and 
month of lactation, respectively. 
The LC n-3 PUFA status in this pregnant and breastfeeding women was similar to the results 
of previous studies (Markhus et al. 2013; Li et al. 2015; Markhus et al. 2015). Moreover, a 
cross-sectional (Li et al. 2015) and a longitudinal study (Al et al. 1995) also showed a 
decrease in the DHA level from the middle of pregnancy, which continues during the 
breastfeeding period until the 6 month postpartum (Markhus et al. 2015).  
The additional requirement during pregnancy, especially at the end of gestation (Kuipers et 
al. 2012), could be a reason for the lower DHA level in breastfeeding women compared to 
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pregnant women. Moreover, in the breastfeeding period, the DHA loss via breast milk 
(about 100 mg/day) (Kent et al. 2006; Brenna et al. 2007; Brenna & Lapillonne 2009) is 
higher than in the last weeks of gestation, where the fetus accumulates approximately 
40 mg/day DHA (Kuipers et al. 2012).  
The current study measured only the relative LC n-3 PUFA status. However, even if the total 
lipid level increases during pregnancy (Mankuta et al. 2010), the absolute DHA level also 
decreases with the time of pregnancy (Li et al. 2015).  
 
Middle-aged women (Paper IV) 
 The average DHA level was 4.66 ± 1.01% and the omega-3 index was 5.49 ± 1.17%. 
 A total of 62.8% demonstrated a low omega-3 index value (> 4 - 6%), and high omega-3 
index values (≥ 8%) were only present in 2.7% of the women.  
 
The assessment of the LC n-3 PUFA status in both study collectives compared with 
previous studies 
The results of the LC n-3 PUFA status in both collectives correspond with extrapolated data 
of German adults, where the LC n-3 PUFA is classified as very low (> 4 - 6%) (Stark et al. 
2016). In a European-wide comparison of the general population, the LC n-3 PUFA status 
was lower in these both groups than the extrapolated LC n-3 PUFA status of other countries 
such as in Sweden and Finland, where a moderate omega-3 index (> 6 - 8%) is prevalent, or 
in Denmark and Norway, where the omega-3 index is high (> 8%) (Stark et al. 2016).  
The plant n-3 PUFA intake in Germany is similar to these countries (Micha et al. 2014). 
However, the seafood n-3 PUFA intake, which reflects the EPA and DHA intake, is lower in 
German women compared to these countries. In Finland, the seafood n-3 PUFA intake is 
450 - 549 mg/day, and in Denmark and Norway the intake is ≥ 550 mg/day (Micha et al. 
2014). In contrast, the average intake of EPA and DHA of German women is less than 
200 mg/day (DGE 2012) and therefore below the recommendations of at least 200 mg/day 
DHA alone or in combination with EPA (ISSFAL 2004; Koletzko et al. 2007; Kris-Etherton et 
al. 2007; EFSA 2010; D-A-CH 2015; DeSalvo et al. 2016).  
The lower LC n-3 PUFA status in both groups could also be the result of a low prevalence of 
LC n-3 PUFAs supplementation. For example, a total of 56.0% of the general population in 
Norway supplement LC n-3 PUFAs (Saga et al. 2012). In this study, none of the middle-aged 
women took LC n-3 PUFA supplements, and in the pregnant and breastfeeding women, the 
prevalence of LC n-3 PUFA supplementation was 11.5%. In the general population of 
Germany, the prevalence of fish oil supplementation is below 1.0% (DGE 2012). Moreover, 
assuming that an omega-3 index ≥ 8% also applies for pregnant and breastfeeding women, a 
total of 59.0% of the pregnant and breastfeeding women in this study, who took the 
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recommended DHA supplementation (200 mg/day) (Koletzko et al. 2007; D-A-CH 2015), 
showed an omega-3 index below 8%. However, the beginning and regular intake of this 
supplementation was unknown.  
 
Influencing factors on the LC n-3 PUFA status 
Several factors were identified that affected the LC n-3 PUFA status: 
 Smoking have a negative influence on the omega-3 index in both study groups, as 
shown previously, where smoking was inversely associated with the DHA level (Simon et 
al. 1996; Scaglia et al. 2016; Zaparoli et al. 2016) and omega-3 index (Block et al. 2008). 
Probably oxidative stress (Pasupathi et al. 2009) and a lower formation of PUFAs 
(Pawlosky et al. 1999) is responsible, but the exact effect of smoking is unknown. 
 The influence of age was examined in middle-aged women, and was related with a higher 
EPA level and omega-3 index in women ≥ 50 years of age compared to women between 
40 and 49 years of age. An increased intake of LC n-3 PUFAs with age is assumed to be 
the reason for the higher LC n-3 PUFA status (Harris et al. 2013). However, data of the 
German nutrition report demonstrated only a slightly higher intake of EPA and DHA in 
women 51 - 64 years of age in comparison with younger women (35 - 50 years) (EPA 65 
versus 57 mg/day, DHA 119 versus 108 mg/day) (DGE 2012). 
 Hormonal contraceptive users showed a lower EPA/ALA ratio and a higher DHA/EPA 
ratio in middle-aged women compared to women who did not use OCs. These findings 
might result from estrogen, which is suggested to increase the conversion from ALA to 
DHA by enhancement of the desaturation/elongation pathway (Burdge & Wootton 2002; 
Giltay et al. 2004; Kitson et al. 2013). A significant difference between the DHA level and 
omega-3 index were not detected in this study. Nevertheless, the probably positive effect of 
estrogen was shown in women who use hormonal replacement therapy (HRT) – their LC n-
3 PUFA status did not vary from women who did not use hormones. This indicates that 
HRT is may be effective enough to compensate for the hormone deficiency during this life 
phase. 
The effect of estrogen may be also responsible for the higher prevalence of omega-3 index 
≥ 8% in pregnant women (17.4%) than in middle-aged women (2.7%) and breastfeeding 
women (5.5%) due to the increase of the estrogen level during pregnancy (Schock et al. 
2016). 
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3.3. Iron status in women of reproductive age (Paper V) 
Iron is important in women of reproductive age due to menstruation-related iron losses 
(Napolitano et al. 2014) and the increased iron requirements in case of a potential 
forthcoming pregnancy (Bothwell 2000). The assurance of the iron status is challenging 
because several factors affect the iron status (Cable et al. 2012; Collings et al. 2013; 
Napolitano et al. 2014; Weinborn et al. 2015), and therefore the requirement of iron.  
 
Main results and the assessment of iron status with previous studies 
 An inadequate iron status was prevalent in 16.3 % of the women (18 - 34 years). A total 
of 13.5% demonstrated iron deficiency without anemia (ferritin < 20 µg/L, hemoglobin 
≥ 12 g/dl), whereas anemia (Hb < 12 g/dL) was shown in 2.8 %.  
 The severe risk of iron overload (ferritin > 150 µg/L) was present in 1.1% of the women. 
A comparison with previous studies is difficult due to the inconsistent use of cutoffs for iron 
deficiency. The prevalence of iron deficiency in this study was possible lower compared to 
the most previous studies. For example, iron deficiency (ferritin < 12 µg/L) was prevalent in 
20.0% of the Finnish women (< 50 years) (Lahti-Koski et al. 2003) and in 9.8% of the US 
women (18 - 49 years) (Miller 2014). Moreover, the prevalence of iron deficiency (ferritin 
< 15 µg/L) in Belgium women (18 - 39 years) was about 20.0% (Pynaert et al. 2007). In 
contrast, a total of 7.3% of the women in this study demonstrated ferritin concentration 
< 15 µg/L. It might be assumed that the prevalence of an inadequate iron status is lower in 
this study than detected due to the increase of ferritin during inflammation (Thurnham et al. 
2010), however, therefore the sTfR concentration was measured.  
With regarding to anemia, the cutoff agree between the studies (Hb < 12 g/dL). The 
prevalence of anemia was comparable with that of Danish women (2.2%) (Milman et al. 
1998). However, the frequency was lower than in Belgian women (nearly 5.0%) (Pynaert et 
al. 2007), Finnish women (5.8%) (Lahti-Koski et al. 2003) and Portuguese women (30.5%) 
(Fonseca et al. 2016).  
 
Factors that influence the iron status 
The differences in the iron status in comparison with previous studies could also be 
explained by the many factors that influence the iron status. The following factors had an 
impact on the iron status in this study: 
 Dietary patterns affect the iron status in this study, as shown previously (Haider et al. 
2016). In omnivorous individuals in this study, the ferritin concentration was higher and the 
sTfR-F index was lower compared to vegetarians. This finding corresponds with the higher 
iron absorption in mixed-diet than in vegetarian diet (Hunt & Roughead 1999, Bach 
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Kristensen et al. 2005), which is possible due to the fact that plant foods contain iron 
inhibitors such as soy protein (Weinborn et al. 2015).  
 Blood donators showed a higher prevalence of depleted iron stores than non-blood 
donators in this study. In previous studies, the prevalence of depleted iron stores (ferritin 
< 15 µg/L) in blood donators was between 39.0% and 50.0% (Booth et al. 2014; Rigas et 
al. 2014). Moreover, the sTfR-F index was also higher in blood donators of this study 
compared to non-blood donators, in such a way that a future iron imbalance could lead to 
an impaired erythropoiesis (Clark 2008). 
 In the self-assessment of menstruation, a higher amount of blood loss during 
menstruation had an adversely effect on the iron status – ferritin concentration and sTfR-F 
index – in this study. These results were in accordance with recent findings where the 
collected menstruation blood loss had a negative impact on the ferritin level (Napolitano et 
al. 2014). Moreover, in this study, the ferritin concentration was also lower in the case of a 
shorter time frame since the last menstruation and a higher intensity of menstruation.  
 The use of OCs was associated with a higher ferritin concentration in this study, which 
could be explained by shorter bleeding times (Milman et al. 1998) and less blood loss 
(Fraser et al. 2012) due to the use of OCs. However, the prevalence of depleted iron stores 
did not depend on OC use. The positive impact of OCs on the iron status only appears to 
be attributed with the use of OCs of micro pills (fourth progestin generation) like dienogest. 
These OCs have an antiandrogen activity (Schindler et al. 2003) that leads to a lower 
bleeding rate and rare intermenstrual bleeding (Golbs et al. 2002). In contrast, the OC of 
the second and third progestin generation had no influence on the iron status in this study, 
which is in accordance with a previous study that examined the influence of the OCs of the 
third progestin generation (Casabellata et al. 2007). 
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4. General conclusion and perspectives 
The main results of this thesis are shown in Figure 5.  
Figure 5 Status of specific nutrients in women during certain stages of life. 
Abbreviations: -, negative influence; +, positive influence; (+), probably positive influence; anemia, 
hemoglobin < 12 g/dL; iron deficiency without anemia, ferritin < 20 µg/L and hemoglobin ≥ 12 g/dL; LC 
n-3 PUFA, long-chain omega-3 polyunsaturated fatty acids; NPNB, non-pregnant, non-breastfeeding 
women; omega-3 index, relative eicosapentaenoic acid and docosahexaenoic acid concentration in 
relation to the total fatty acids in erythrocyte membranes; high omega 3-index, omega-3 index ≥ 8%. 
 
Pregnant and breastfeeding women demonstrated a high prevalence of an inadequate 
vitamin D status and are risk groups for vitamin D deficiency (25(OH)D < 25.0 nmol/L) 
compared to NPNB women (Paper I and II). Also, the majority of NPNB women showed a 
low vitamin D status. Firstly, the determination of the vitamin D status with the highest health 
advantage for these groups is required to ensure optimal health of mother, fetus and infant 
during pregnancy and breastfeeding period (Aghajafari et al. 2013; Zhu et al. 2014; Achkar et 
al. 2015; Lu et al. 2016). Nevertheless, the vitamin D status needs to be improved in most of 
these women, regardless of the target value (≥ 50.0 or ≥ 75.0 nmol/L). General strategies are 
required to ensure an adequate vitamin D status because foods contain only a small amount 
of vitamin D (Souci et al. 2015) and the endogenous vitamin D synthesis seems to be 
inadequate in this study population to ensure an adequate vitamin D status. As the use of 
sunscreen reduces the vitamin D synthesis capability (Matsuoka et al. 1987), one opportunity 
is the development of sunscreens that reduce erythema but also enhance the vitamin D 
synthesis. In vitro, the development of these sunscreens has been shown (Kockott et al. 
2016). Another additional possibility is the vitamin D supplementation and fortification. The 
effectiveness of a vitamin D supplementation, which dose corresponds to the 
recommendation of DGE (20 µg/day), has been confirmed to achieve 25(OH)D 
concentrations ≥ 50.0 nmol/L in 99% of women of reproductive age (Pilz et al. 2017). In 
addition, a vitamin D fortification of staple food might be another opportunity to increase the 
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vitamin D status, as it has been shown in different interventions studies (Bakker et al. 2009; 
Black et al. 2012; Allen et al. 2015; Nikooyeh et al. 2016). Further studies are required to 
examine which foods are suitable to increase and maintain the vitamin D status. 
Furthermore, a correct selection of foods is necessary to ensure the improvement the 
vitamin D status of the whole population. Therefore, the EU-funded project “Food-based 
solutions for optimal vitamin D nutrition and health through the life cycle” has been initiated, 
which intention is the establishment of food-based strategies to avoid inadequate vitamin D 
status (Kiely et al. 2015). 
The LC n-3 PUFA status is probably inadequate in the most pregnant and breastfeeding 
women (Paper III). Further studies are required to ascertain the accurate assessment of a 
favorable LC n-3 PUFA status during pregnancy and breastfeeding periods. In the majority of 
middle-aged women, the LC n-3 PUFA status is insufficient (Paper IV) and might be a risk 
factor for several health consequences, such as cardiovascular death (Harris & Schacky 
2004). Therefore, the LC n-3 PUFA status in middle-aged women should be enhanced. 
Altogether, strategies should be developed to improve the LC n-3 PUFA status. The use of 
vegetable oils (source of ALA) does not appear to be sufficient (Egert et al. 2012; Salem & 
Eggersdorfer 2015) due to the limited conversion rate from ALA to DHA (Plourde & Cunnane 
2007; Brenna et al. 2009). For this reason, reference values for the dietary intake of LC n-3 
PUFAs are necessary. The consume of fish or a fish oil supplementation are supporting 
opportunities to improve the LC n-3 PUFA status. An intake of 1 g/day of fish or fish oil over 
12 weeks increases the omega-3 index by an average of 1.01% and 1.70%, respectively 
(Brazionis et al. 2012). However, the present availability of fish oil and fish will not be 
sufficient to ensure a desirable LC n-3 PUFA status for the world population (Salem & 
Eggersdorfer 2015). Alternative sources of LC n-3 PUFAs are microalgae oil (Ryckebosch et 
al. 2014) or Antarctic krill (Gigliotti et al. 2011). An average microalgae oil intake of at least 
2 g/day is already sufficient for the most microalgae species to ensure a daily consumption of 
250 mg LC n-3 PUFA (Ryckebosch et al. 2014). Moreover, LC n-3 PUFAs fortification of 
foods is a further alternative to enhance the LC n-3 PUFA status (Egert et al. 2012). 
The iron status in women of reproductive age was not worrying (Paper V). However, women 
in this life phase should still ensure the intake of sufficient iron in a highly available form to 
sustain the iron status, which is especially important when pregnancy is planned (Breymann 
2015). Guidelines are necessary to instruct women about the different iron sources and their 
bioavailability. 
Finally, educational work is required to inform the population about the critical supply 
situation with these nutrients and how these supply situation can be improved.  
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